UK markets closed
NIKKEI 225
38,274.05 -131.61 (-0.34%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
79.16 -2.77 (-3.38%) GOLD FUTURES
2,309.80 +6.90 (+0.30%) DOW
37,950.55 +134.63 (+0.36%) Bitcoin GBP
45,778.91 -2,294.55 (-4.77%)
Amneal Pharmaceuticals, Inc. (AMRX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:43PM EDT. Market open.
| Previous close | 6.05 |
| Open | 6.01 |
| Bid | 6.01 x 600 |
| Ask | 6.04 x 200 |
| Day's range | 6.01 - 6.19 |
| 52-week range | 1.74 - 6.46 |
| Volume | |
| Avg. volume | 1,574,906 |
| Market cap | 1.862B |
| Beta (5Y monthly) | 1.35 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
BRIDGEWATER, N.J., April 24, 2024--Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
- Business Wire
Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine
BRIDGEWATER, N.J., April 16, 2024--Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine
- Business Wire
Amneal to Report First Quarter 2024 Results on May 3, 2024
BRIDGEWATER, N.J., April 10, 2024--Amneal to Report First Quarter 2024 Results on May 3, 2024
© 2024 Yahoo. All rights reserved.